Financings
Orogen Royalties Announces Non-Brokered Private Placement of up to $10 Million

OGN · Price
Executive Summary
- Orogen Royalties Inc. announced a non‑brokered private placement to raise up to $10 million by issuing up to 2,890,274 common shares at $3.46 per share.
- Proceeds will be used for generative exploration initiatives, potential royalty acquisitions, and to bolster working capital for growth.
- The placement includes a 5% cash finder's fee on shares sold through introduced investors, a four‑month hold period on the issued shares, and may involve participation by directors/officers as a related‑party transaction exempt from certain MI 61‑101 approvals.
Key Details
- Offering Size: Up to $10,000,000 total gross proceeds.
- Shares Offered: Up to 2,890,274 common shares.
- Price per Share: $3.46 CAD.
- Use of Proceeds:
- Development of generative exploration projects.
- Execution of potential royalty acquisitions.
- Strengthening working capital for ongoing growth strategy.
- Related‑Party Participation: Directors and officers may purchase shares; transaction exempt from formal valuation/minority shareholder approval because it does not exceed 25 % of market cap.
- Finder’s Fee: 5 % cash fee on shares sold to investors introduced by finders, subject to TSX Venture Exchange approval.
- Hold Period: All issued shares subject to a four‑month hold period under Canadian securities laws and applicable foreign hold periods from closing date.
- Closing Timeline: Anticipated within approximately 3–4 weeks of the announcement, contingent on regulatory and exchange approvals.
- Regulatory Notices: No offer or solicitation in the United States; shares not registered under U.S. securities laws.
Notable Quotes
- “The private placement will provide us with the capital needed to advance our exploration programs and pursue strategic royalty acquisitions, positioning Orogen for continued growth.” – Paddy Nicol, President & CEO
All forward‑looking statements are subject to risks and uncertainties that could cause actual results to differ materially.
More from Orogen Royalties Inc.
Jun 30, 2026 · 07:30